When my interview about the FDA-released Pfizer document went from viral viewing to violating YouTube’s guidelines.
By Sonia Elijah
On Dec 14, Trial Site News published my investigative report on a 38-page Pfizer document, entitled, “Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) received through 28 February 2021,” released by the FDA through a FOIA request.
The article created quite a storm and garnered worldwide attention. A few days later, I was contacted by a journalist from Kalkine Media Australia for an interview. The interview was split into two parts and posted on Kalkine Media’s YouTube channel on Dec 17, within the space of a few hours it received tens of thousands of views and hundreds of comments. By the 20th , Part 1 of the interview was watched over 1.2 million times, clocking up over 7000 comments and 28,000 likes. Kalkine Media’s YouTube channel subscription almost doubled. There was no doubt about it, the interview had gone viral.
The momentum ended abruptly, when both parts of the interview were removed by YouTube on the 21st. I sent out a message on Twitter, highlighting this flagrant act of censorship b...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).